Oral BPC-157 for Gastrointestinal Conditions Injectable BPC-157 for Musculoskeletal Conditions Injection Technique and Patient Education All patients receiving injectable BPC-157 are provided with: Detailed written instructions for reconstitution, storage, and administration In-person or video training on proper subcutaneous injection technique Sharps disposal containers and guidance on safe disposal 24-hour clinical contact for questions or concerns Most patients self-administer injections after the first week of supervised dosing
TB-500 drives cellular mobilisation, particularly promoting the migration of keratinocytes, endothelial cells, and stem/progenitor cells to sites of tissue disruption, while simultaneously suppressing inflammatory and apoptotic signalling
Always use sterile syringes and vials when handling the peptide
Some have sited peptides stored at 39F have experienced minimal degradation
No lethal dose has been established, and animal models show a very high safety threshold
Some people benefit from weekly injections, while others only need them monthly
